TY  - GEN
AU  - Gomes,Lenyta Oliveira
AU  - Teixeira,Marina Rodrigues
AU  - Rosa,Júnior André da
AU  - Feltrin,Alberi Adolfo
AU  - Rodrigues,João Paulo V
AU  - Vecchi,Mariane D'Avila
AU  - Carneiro,Jane Meire M
AU  - Noblat,Lúcia de Araújo C B
AU  - Chachá,Silvana Gama F
AU  - Martinelli,Ana de Lourdes C
AU  - Pereira,Leonardo Regis L
AU  - Silveira,Marysabel Pinto T
AU  - Blatt,Carine Raquel
AU  - Farias,Mareni Rocha
TI  - Hepatitis C in Brazil: lessons learned with boceprevir and telaprevir
SN  - 1678-9946
PY  - 2018///0710
KW  - Antiviral Agents
KW  - administration & dosage
KW  - Clinical Protocols
KW  - Decision Making
KW  - Drug Therapy, Combination
KW  - Female
KW  - Genotype
KW  - Hepacivirus
KW  - genetics
KW  - Hepatitis C, Chronic
KW  - drug therapy
KW  - Humans
KW  - Interferon alpha-2
KW  - Interferon-alpha
KW  - Male
KW  - Middle Aged
KW  - Oligopeptides
KW  - Polyethylene Glycols
KW  - Proline
KW  - Protease Inhibitors
KW  - Recombinant Proteins
KW  - Retrospective Studies
KW  - Ribavirin
N1  - Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study
UR  - https://doi.org/10.1590/s1678-9946201860029
ER  -